← Back to Search

2 for Post-Traumatic Stress Disorder (Hypnosis Trial)

N/A
Waitlist Available
Led By Tara Galovski, PhD
Research Sponsored by Center for Trauma Recovery, St Louis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants will be at least three months post-crime at the time of their participation and will have been diagnosed with PTSD. Participants will score at least a "3" on the CAPS symptom of sleep impairment. This score is indicative of clinically significant symptomatology on any PTSD symptom. There is no upper limit on time since the trauma for participation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post-treatment
Awards & highlights

Hypnosis Trial Summary

Sleep impairment is the most often reported of the 17 PTSD symptoms and is considered one of the most refractory to treatment. This study proposes the use of sleep-directed hypnotherapy to address sleep issues as a complementary element to empirically supported Cognitive Processing Therapy (CPT) in treating PTSD in sexual and physical assault survivors. Specifically the study aims to: 1) compare the results of sleep-directed hypnosis plus CPT with CPT only, 2) to assess the relationship between sleep and PTSD symptoms, 3) to examine relationships between sleep improvement, PTSD symptom improvement, and the therapeutic elements (hypnosis, exposure, cognitive therapy) to determine mechanisms of action in the intervention, 4) to assess the relationship between sleep and physical reactivity to trauma-related cues and to other stimuli.

Eligible Conditions
  • Post-Traumatic Stress Disorder

Hypnosis Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Hypnosis Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Good end-state functioning: Beck Depression Inventory-II and Posttraumatic Distress Scale Scores

Hypnosis Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment2 Interventions
Hypnosis plus Cognitive Processing Therapy.
Group II: 1Active Control1 Intervention
Cognitive Processing Therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~3400
Hypnosis
2006
Completed Phase 4
~1300

Find a Location

Who is running the clinical trial?

Center for Trauma Recovery, St LouisLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
831 Previous Clinical Trials
668,883 Total Patients Enrolled
Tara Galovski, PhDPrincipal InvestigatorCenter for Trauma Recovery, University of Missouri- St. Louis
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025